MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure

Biochemical and Biophysical Research Communications

Volumn 451, Issue 4, 2014, Pages 516-521

  Möhnle, Patrick ^a   Schütz, Stefanie Veronika ^a   Schmidt, Marc ^a   Hinske, Christian ^a   Hübner, Max ^a   Heyn, Jens ^a   Beiras Fernandez, Andres ^b   Kreth, Simone ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

CB1; CB2; Endocannabinoid system; MicroRNA

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; MICRORNA; MICRORNA 665; UNCLASSIFIED DRUG; MIRN494 MICRORNA, HUMAN; MIRN665 MICRORNA, HUMAN;

ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OPEN HEART SURGERY; PROTEIN EXPRESSION; BIOSYNTHESIS; CB1; CB2; DRUG EFFECT; ENDOCANNABINOID SYSTEM; HEART FAILURE; METABOLISM; PHYSIOLOGY;

CB1; CB2; ENDOCANNABINOID SYSTEM; MICRORNA;

HEART FAILURE; HUMANS; MICRORNAS; MYOCYTES, CARDIAC; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 84908373337     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.08.008     Document Type: Article

References (32)

1. F. Montecucco, and V. Di Marzo At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction Trends Pharmacol. Sci. 33 2012 331 340
2. C.R. Hiley Endocannabinoids and the heart J. Cardiovasc. Pharmacol. 53 2009 267 276
3. V. Di Marzo The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation Pharmacol. Res. 60 2009 77 84
4. F. Montecucco, S. Lenglet, V. Braunersreuther, F. Burger, G. Pelli, M. Bertolotto, F. Mach, and S. Steffens CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion J. Mol. Cell. Cardiol. 46 2009 612 620
5. N. Defer, J. Wan, R. Souktani, B. Escoubet, M. Perier, P. Caramelle, S. Manin, V. Deveaux, M.C. Bourin, A. Zimmer, S. Lotersztajn, F. Pecker, and C. Pavoine The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy FASEB J. 23 2009 2120 2130
6. A.R. Hajrasouliha, S. Tavakoli, M. Ghasemi, P. Jabehdar-Maralani, H. Sadeghipour, F. Ebrahimi, and A.R. Dehpour Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart Eur. J. Pharmacol. 579 2008 246 252
7. B. Kola, E. Hubina, S.A. Tucci, T.C. Kirkham, E.A. Garcia, S.E. Mitchell, L.M. Williams, S.A. Hawley, D.G. Hardie, A.B. Grossman, and M. Korbonits Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase J. Biol. Chem. 280 2005 25196 25201
8. J.A. Wagner, K. Hu, J. Karcher, J. Bauersachs, A. Schafer, M. Laser, H. Han, and G. Ertl CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction Br. J. Pharmacol. 138 2003 1251 1258
9. J.A. Wagner, M. Abesser, J. Karcher, M. Laser, and G. Kunos Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts J. Cardiovasc. Pharmacol. 46 2005 348 355
10. P. Mukhopadhyay, S. Batkai, M. Rajesh, N. Czifra, J. Harvey-White, G. Hasko, Z. Zsengeller, N.P. Gerard, L. Liaudet, G. Kunos, and P. Pacher Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity J. Am. Coll. Cardiol. 50 2007 528 536
11. P. Mukhopadhyay, M. Rajesh, S. Batkai, V. Patel, Y. Kashiwaya, L. Liaudet, O.V. Evgenov, K. Mackie, G. Hasko, and P. Pacher CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes Cardiovasc. Res. 85 2010 773 784
12. S. Slavic, D. Lauer, M. Sommerfeld, U.R. Kemnitz, A. Grzesiak, M. Trappiel, C. Thone-Reineke, J. Baulmann, L. Paulis, K. Kappert, U. Kintscher, T. Unger, and E. Kaschina Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome J. Mol. Med. (Berl.) 91 2013 811 823
13. S. Batkai, P. Mukhopadhyay, J. Harvey-White, R. Kechrid, P. Pacher, and G. Kunos Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats Am. J. Physiol. Heart Circ. Physiol. 293 2007 H1689 H1695
14. F. Weis, A. Beiras-Fernandez, R. Sodian, I. Kaczmarek, B. Reichart, A. Beiras, G. Schelling, and S. Kreth Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure J. Mol. Cell. Cardiol. 48 2010 1187 1193
15. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
16. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
17. R. Kumarswamy, and T. Thum Non-coding RNAs in cardiac remodeling and heart failure Circ. Res. 113 2013 676 689
18. S. Perez, L.J. Royo, A. Astudillo, D. Escudero, F. Alvarez, A. Rodriguez, E. Gomez, and J. Otero Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors BMC Mol. Biol. 8 2007 114
19. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
20. M. Kertesz, N. Iovino, U. Unnerstall, U. Gaul, and E. Segal The role of site accessibility in microRNA target recognition Nat. Genet. 39 2007 1278 1284
21. E. van Rooij, L.B. Sutherland, J.E. Thatcher, J.M. DiMaio, R.H. Naseem, W.S. Marshall, J.A. Hill, and E.N. Olson Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc. Natl. Acad. Sci. U.S.A. 105 2008 13027 13032
22. T. Thum, C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, P. Galuppo, S. Just, W. Rottbauer, S. Frantz, M. Castoldi, J. Soutschek, V. Koteliansky, A. Rosenwald, M.A. Basson, J.D. Licht, J.T. Pena, S.H. Rouhanifard, M.U. Muckenthaler, T. Tuschl, G.R. Martin, J. Bauersachs, and S. Engelhardt MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 456 2008 980 984
23. S. Roy, S. Khanna, S.R. Hussain, S. Biswas, A. Azad, C. Rink, S. Gnyawali, S. Shilo, G.J. Nuovo, and C.K. Sen MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue Cardiovasc. Res. 82 2009 21 29
24. D. Sayed, C. Hong, I.Y. Chen, J. Lypowy, and M. Abdellatif MicroRNAs play an essential role in the development of cardiac hypertrophy Circ. Res. 100 2007 416 424
25. T.E. Callis, K. Pandya, H.Y. Seok, R.H. Tang, M. Tatsuguchi, Z.P. Huang, J.F. Chen, Z. Deng, B. Gunn, J. Shumate, M.S. Willis, C.H. Selzman, and D.Z. Wang MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice J. Clin. Invest. 119 2009 2772 2786
26. Y. Lu, Y. Zhang, H. Shan, Z. Pan, X. Li, B. Li, C. Xu, B. Zhang, F. Zhang, D. Dong, W. Song, G. Qiao, and B. Yang MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection Cardiovasc. Res. 84 2009 434 441
27. P. Fasanaro, Y. D'Alessandra, V. Di Stefano, R. Melchionna, S. Romani, G. Pompilio, M.C. Capogrossi, and F. Martelli MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3 J. Biol. Chem. 283 2008 15878 15883
28. A. Bonauer, G. Carmona, M. Iwasaki, M. Mione, M. Koyanagi, A. Fischer, J. Burchfield, H. Fox, C. Doebele, K. Ohtani, E. Chavakis, M. Potente, M. Tjwa, C. Urbich, A.M. Zeiher, and S. Dimmeler MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice Science 324 2009 1710 1713
29. Y.L. Liu, W. Wu, Y. Xue, M. Gao, Y. Yan, Q. Kong, Y. Pang, and F. Yang MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation Arch. Virol. 158 2013 1953 1963
30. G.K. Wang, J.Q. Zhu, J.T. Zhang, Q. Li, Y. Li, J. He, Y.W. Qin, and Q. Jing Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans Eur. Heart J. 31 2010 659 666
31. Y. Goren, M. Kushnir, B. Zafrir, S. Tabak, B.S. Lewis, and O. Amir Serum levels of microRNAs in patients with heart failure Eur. J. Heart Fail. 14 2012 147 154
32. N. Nair, S. Kumar, E. Gongora, and S. Gupta Circulating miRNA as novel markers for diastolic dysfunction Mol. Cell. Biochem. 376 2013 33 40